Neuberger Berman Group
STJ

Neuberger Berman Group’s St Jude Medical STJ Stock Holding History

Neuberger Berman Group’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-20,855
Closed -$1.67M – 1700
2016
Q4 		$1.67M Sell
20,855
-493
-2% -$39.1K ﹤0.01% 1031
2016
Q3 		$1.7M Sell
21,348
-3,779
-15% -$305K ﹤0.01% 996
2016
Q2 		$1.96M Buy
+25,127
New +$1.79M ﹤0.01% 979
2016
Q1 		– Sell
-3,417
Closed -$211K – 1556
2015
Q4 		$211K Buy
+3,417
New +$216K ﹤0.01% 1441

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Neuberger Berman Group's STJ Position: Q1 2017 in Review

Neuberger Berman Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 20,855 shares — an estimated $1.67M sold.

Neuberger Berman Group first reported a position in STJ in Q4 2015 and held it in 4 quarters. The position peaked at $1.96M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Neuberger Berman Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Neuberger Berman Group sold 20,855 St Jude Medical shares in Q1 2017, an estimated $1.67M.
  • Neuberger Berman Group first reported a position in St Jude Medical in Q4 2015 and held it in 4 quarters.
  • Neuberger Berman Group's St Jude Medical position peaked at $1.96M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Neuberger Berman Group's 13F filing for Q1 2017, filed 10 May 2017.